Sign in
8-K

Current Report

Oruka Therapeutics, Inc. Filed Acc 0001564590-22-034773

Director nominations

  • Item 5.08 Shareholder director nominations

From the SEC's structured data for this filing

Loading abio-8k_20221020.htm…